Omalizumab in Refractory Adult-Onset Facial Atopic Dermatitis: A Case Report. (PubMed, Clin Cosmet Investig Dermatol) - Oct 8, 2026 - "Symptom-related scores decreased, and no adverse events were observed in this case. This case suggests that even in the absence of a typical atopic history, omalizumab may represent a potential therapeutic option for patients with adult-onset facial atopic dermatitis who exhibit elevated serum IgE levels and poor responses to conventional treatments."
Journal • Atopic Dermatitis • Dermatitis • Dermatology • Immunology • Pruritus • Rosacea
|
|
Yang Xu; Yiqiong Zhang; Yixuan Liu; Yuehong Guo; Zhanchao Zhou
|